TUBB3 and intrahepatic cholangiocarcinoma: Upon treatment with either CDK4/6 inhibitor alone, or in combination with RA, ICC showed an increase in TUBB3 expression and neurite extension (compared to DMSO or RA treatment) (Figure 2C).